Monday, 16 November 2026Follow on 𝕏

Regulatory Page 4

Regulatory

FDA National Priority Vouchers for Psychedelics

An April 2026 executive order from Donald Trump introduces major changes to how psychedelic drugs could be reviewed and accessed in the U.S. The policy creates two new pathways: a faster U.S. Food and Drug Administration review process…